Search Results
Jul 30, 2026, 12:33 ET Piramal Pharma Limited annuncia i risultati del primo trimestre dell'anno fiscale 2027
17 % PCH347
More news about: Piramal Pharma Limited
Jul 30, 2026, 10:31 ET Piramal Pharma Limited annonce ses résultats pour le T1 2027
17 % PCH347
More news about: Piramal Pharma Limited
Jul 30, 2026, 07:02 ET Piramal Pharma Limited、27年度第1四半期の業績を発表
17 % PCH347
More news about: Piramal Pharma Limited
Jul 30, 2026, 06:39 ET Piramal Pharma Limited gibt die Ergebnisse für das erste Quartal des Geschäftsjahres 2027 bekannt
17 % PCH347
More news about: Piramal Pharma Limited
Jul 30, 2026, 04:27 ET Piramal Pharma Limited anuncia sus resultados para el primer trimestre del año fiscal 2027
17 % PCH347
More news about: Piramal Pharma Limited
Jul 29, 2026, 15:38 ET Piramal Pharma Limited Announces Results for Q1 FY27
17 % PCH347
More news about: Piramal Pharma Limited
Jul 29, 2026, 15:27 ET Piramal Pharma Limited Announces Results for Q1 FY27
17 % PCH347
More news about: Piramal Pharma Limited
May 05, 2026, 08:39 ET The Dyrt Creates Comprehensive Pacific Coast Highway Road Trip and Camping Guide Presented by T-Mobile
San Diego."There are so many iconic road trips and amazing camping properties all over the country, but the sheer beauty of traveling along the PCH and
More news about: The Dyrt
May 01, 2026, 00:35 ET Piramal Pharma Limited annuncia i risultati del quarto trimestre e dell'intero esercizio 2026
approvvigionamento.Piramal Consumer Healthcare (PCH):I marchi di punta hanno mantenuto lo slancio di crescita con un aumento del 24% su base annua nell'anno fiscale 2026, contribuendo per il 52% alle vendite PCH. Little's, Lacto Calamine, CIR e i-range sono rimasti
More news about: Piramal Pharma Limited
Apr 30, 2026, 16:19 ET Piramal Pharma Limited、FY26第4四半期および通期決算を発表
3 % PCH320
More news about: Piramal Pharma Limited
Apr 30, 2026, 16:10 ET Piramal Pharma Limited annonce ses résultats pour le quatrième trimestre et l'exercice 2026
d'approvisionnement.Piramal Consumer Healthcare (PCH) :Power Brands a poursuivi sa dynamique de croissance avec une progression de 24 % en glissement annuel en 2026, contribuant à hauteur de 52 % aux ventes de PCH. Little's, Lacto Calamine, CIR et i-range sont restés
More news about: Piramal Pharma Limited
Apr 30, 2026, 12:34 ET Piramal Pharma Limited gibt Ergebnisse für das vierte Quartal und das Gesamtjahr des Geschäftsjahres 2026 bekannt
Lieferengpässe zu beheben.Piramal Consumer Healthcare (PCH):Power Brands setzten ihre Wachstumsdynamik mit einem Wachstum von 24 % gegenüber dem Vorjahr im GJ26 fort und trugen 52 % zum PCH-Umsatz bei. Little's, Lacto Calamine, CIR sowie i-range blieben die
More news about: Piramal Pharma Limited
Apr 29, 2026, 14:27 ET Piramal Pharma Limited anuncia los resultados del cuarto trimestre y del ejercicio fiscal 2026
suministro.Piramal Consumer Healthcare (PCH):Las marcas líderes mantuvieron su impulso de crecimiento con un aumento interanual del 24 % en el año fiscal 2026, contribuyendo con el 52 % a las ventas de PCH. Little's, Lacto Calamine, CIR e i-range siguieron
More news about: Piramal Pharma Limited
Apr 28, 2026, 15:51 ET Piramal Pharma Limited Announces Results for Q4 and Full-year FY26
our supplier to resolve supply constraints.Piramal Consumer Healthcare (PCH):Power Brands continued growth momentum with 24% YoY growth in FY26, contributing 52% to PCH sales. Little's, Lacto Calamine, CIR, and i-range remained primary driver of growth.New
More news about: Piramal Pharma Limited
Apr 28, 2026, 15:40 ET Piramal Pharma Limited Announces Results for Q4 and Full-year FY26
our supplier to resolve supply constraints.Piramal Consumer Healthcare (PCH):Power Brands continued growth momentum with 24% YoY growth in FY26, contributing 52% to PCH sales. Little's, Lacto Calamine, CIR, and i-range remained primary driver of growth.New
More news about: Piramal Pharma Limited
Apr 07, 2026, 08:00 ET Alzamend Neuro Reports Encouraging Pharmacodynamic Data from Phase II Clinical Trial of AL001 "Lithium in Brain" Study in a Trial Conducted at Massachusetts General Hospital
across 18 brain regions. The five metabolites analyzed were: total creatine (Cr+PCr), glutamate (Glu), glycerophosphocholine plus phosphocholine (GPC+PCh), myo-inositol (Ins), and N-acetylaspartate plus N-acetylaspartylglutamate (NAA+NAAG). Statistical analyses used the Wilcoxon signed-rank test and
More news about: Alzamend Neuro, Inc.
Feb 02, 2026, 14:41 ET Piramal Pharma Solutions presenta capacidades de comprimido en cápsula
desarrollo y fabricación por contrato; Piramal Critical Care (PCC), una compleja división de genéricos hospitalarios; y Piramal Consumer Healthcare (PCH), que vende productos de consumo y bienestar sin receta. Además, una de las empresas asociadas de PPL, Abbvie Therapeutics India Private Limited, una
More news about: Piramal Pharma Solutions
Jan 31, 2026, 07:57 ET Piramal Pharma Limited annuncia i risultati del terzo trimestre e dei primi nove mesi dell'anno fiscale 2026
Consumer Healthcare (PCH): I marchi di punta hanno continuato a rafforzarsi con una crescita del 30/23% su base annua nel terzo trimestre/nei primi nove mesi dell'anno fiscale 2026, contribuendo al 51% delle vendite totali PCH. La crescita è stata
More news about: Piramal Pharma Limited
Jan 30, 2026, 03:07 ET Piramal Pharma Limited gibt Ergebnisse für das dritte Quartal und die ersten neun Monate des Geschäftsjahres 2026 bekannt
Consumer Healthcare (PCH):Die Power Brands legten im dritten Quartal/in den ersten neun Monaten des Geschäftsjahres 2026 mit einem Wachstum von 30 %/23 % gegenüber dem Vorjahr weiter zu und trugen 51 % zum Gesamtumsatz von PCH bei. Das Wachstum
More news about: Piramal Pharma Limited
Jan 29, 2026, 13:24 ET Piramal Pharma Limited anuncia resultados del tercer trimestre y nueve meses del año fiscal 2026
el 12% de las ventas de PCH en medios y promociones en los 9 meses del año fiscal 2026.Las ventas de comercio electrónico crecieron un 50% interanual en los 9 meses del año fiscal 2026, contribuyendo aproximadamente al 26% de las ventas de PCH. Más del 40% de las ventas
More news about: Piramal Pharma Limited
Jan 29, 2026, 13:17 ET Piramal Pharma Limited annonce ses résultats pour le troisième trimestre et les neuf premiers mois de l'exercice 2026
Healthcare (PCH) : Les marques phares se sont renforcées avec une croissance de 30 %/23 % en glissement annuel au cours du troisième trimestre/des 9 premiers mois de l'exercice 2026, contribuant à 51 % des ventes totales de PCH. La croissance
More news about: Piramal Pharma Limited
Jan 29, 2026, 00:46 ET Piramal Pharma Limited Announces Results for Q3 and 9M FY26
Piramal Consumer Healthcare (PCH): Power Brands grew strength to strength with 30% / 23% YoY growth during Q3 / 9M FY26, contributing to 51% of total PCH sales. Growth was primarily driven by Little's, Lacto Calamine,
More news about: Piramal Pharma Limited
Jan 29, 2026, 00:35 ET Piramal Pharma Limited Announces Results for Q3 and 9M FY26
Piramal Consumer Healthcare (PCH): Power Brands grew strength to strength with 30% / 23% YoY growth during Q3 / 9M FY26, contributing to 51% of total PCH sales. Growth was primarily driven by Little's,
More news about: Piramal Pharma Limited
Jan 27, 2026, 18:02 ET TTM Technologies, Dutch Bros, Advanced Energy Industries, and American Healthcare REIT Set to Join S&P MidCap 400; Others to Join S&P SmallCap 600
conditions. SM Energy will remain in the S&P SmallCap 600 post-merger.Dutch Bros Inc. (NYSE: BROS) will replace PotlatchDeltic Corp. (NASD: PCH) in the S&P MidCap 400 effective prior to the opening of trading on Monday, February 2. S&P MidCap 400 constituent Rayonier Inc. (NYSE: RYN)
More news about: S&P Dow Jones Indices
Jan 08, 2026, 11:53 ET Halper Sadeh LLC Encourages AWK, MBCN, VECO, PCH Shareholders to Contact the Firm to Discuss Their Rights
multimedia:https://www.prnewswire.com/news-releases/halper-sadeh-llc-encourages-awk-mbcn-veco-pch-shareholders-to-contact-the-firm-to-discuss-their-rights-302656567.htmlSOURCE
More news about: Halper Sadeh LLP